Medical Developments International (MDI)
Nathalie Debroas is a seasoned professional with extensive experience in the pharmaceutical and medical sectors. Currently serving as Responsable Grands Comptes at Provepharm since August 2023, Nathalie has held various roles including Account Manager Key Account at Medical Developments International (MDI) since September 2021, focusing on the development of Penthrox. Previous positions include Hospital Representative at BIOGARAN, where Nathalie launched two biosimilar medications, and Déléguée Hospitalière at Aguettant Ltd, concentrating on the development of APOKINON among neurologists. Nathalie's career began at Celltech Pharma S.A., where notable achievements included the launch of multiple products and vaccines. Educational qualifications include a DEUG in Histoire de l'Art et Archéologie from the faculté d'Aix en Provence and a Diplôme National de la Visite Médicale from IFOPS.
This person is not in any offices
Medical Developments International (MDI)
"Delivering emergency medical solutions dedicated to improving patient outcomes" Medical Developments International (MDI) is one of Australia’s leading specialised healthcare companies. With an industry leading range of products in the areas of pain management, asthma and resuscitation, plus veterinary equipment, MDI has supplied healthcare professionals and patients innovative solutions since 1971. MDI is a publicly listed company on the Australian Stock Exchange (ASX) with both its head office and state of the art manufacturing facilities located in Victoria, Australia. MDI manufacture the innovative pain relief product, Penthrox® that has been widely adopted by organisations throughout Australia. MDI has a proud history in human and veterinary medicine, throughout Australia as well as internationally. For over 30 years MDI's key products have helped healthcare professionals achieve better health outcomes for their patients MDI is compliant with Good Manufacturing Practices as well as ISO 13485 for the manufacture of several of its products (including both pharmaceutical and medical products). Several MDI products are also CE marked, enabling them to be sold into the European Community.